Transaction overview
Turpaz Industries Ltd., an Israeli company specializing in flavors, fragrances, and specialty fine ingredients, has acquired Phoenix Flavors & Fragrances Inc., a U.S.-based flavor and fragrance developer and manufacturer. The transaction was completed on May 3, 2026, for $95 million, with the possibility of up to an additional $5 million in contingent consideration based on Phoenix's performance during the second and third quarters of 2026.
Phoenix Flavors & Fragrances is headquartered in Norwood, New Jersey, and develops, manufactures, markets, and sells fragrance extracts primarily for air care, personal care, and home fragrances, as well as flavor extracts for the food and beverage industry. The company serves several hundred customers across the U.S. market and has recently expanded through acquisitions such as Ascent Aromatics (2017), Creative Concepts (2018), and Innovative Fragrances (2022). In 2025, Phoenix reported revenues of $36.8 million with an adjusted EBITDA of $6.9 million.
Deal structure and financing
The acquisition was financed entirely from Turpaz's own resources without the need for external debt or equity contributions. The transaction did not involve any third-party financing, thus avoiding potential regulatory scrutiny associated with leveraged buyouts or significant debt issuance. Stifel, Nicolaus & Company served as the financial advisor to Turpaz Industries in this deal.
Strategic context
The acquisition of Phoenix by Turpaz is a strategic move to establish a full-scale operational platform in North America, a key market for flavors and fragrances. By integrating Phoenix with its existing U.S. operations under Klabin, Turpaz aims to consolidate production and enhance operational efficiencies, particularly through the transfer of Klabin's manufacturing into Phoenix's Norwood facility. This consolidation is expected to result in approximately $2 million in synergies over the coming quarters.
For Phoenix, the rationale for divesting its business aligns with its recent focus on operational restructuring and efficiency improvements. The acquisition allows Phoenix to leverage Turpaz’s global platform for growth and innovation, thereby accelerating its strategic objectives within a larger corporate structure.
Regulatory path
The transaction did not require any significant regulatory approvals due to its size and nature, which are below the thresholds that would trigger antitrust scrutiny in jurisdictions such as the U.S. or EU. However, Turpaz adhered to standard filing requirements in relevant jurisdictions, including HSR filings in the United States, although specific details on the timing of these filings were not disclosed.
The deal’s structure and lack of external financing minimized regulatory hurdles, enabling a swift completion without delays due to merger reviews or required remedies.